Migraine Pipeline Review, H2 2017

MIGRAINE PIPELINE REVIEW, H2 2017 Published Date

Oct 2017

No. of pages

201

Country

Global

Category

Healthcare

Single User License

USD 2000

Mail us - contact@aarkstore.com / Call us - 91 9987295242

SUMMARY Latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Pipeline Review, H2 2017, provides an overview of the Migraine (Central Nervous System) pipeline landscape.

Migraine Pipeline provides complete analysis by stage of development, drug target, mechanism of action, route of administration and molecule type.

Mail us - contact@aarkstore.com / Call us - 91 9987295242

REPORT HIGHLIGHTS Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Migraine Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Migraine (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 4, 12, 14, 12, 21, 4 and 3 respectively.

Migraine (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Mail us - contact@aarkstore.com / Call us - 91 9987295242

SCOPE -

The pipeline guide provides a snapshot of the global therapeutic landscape of Migraine (Central Nervous System).

-

The pipeline guide reviews pipeline therapeutics for Migraine (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

-

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

Mail us - contact@aarkstore.com / Call us - 91 9987295242

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Migraine (Central Nervous System) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Migraine (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Migraine (Central Nervous System)

Mail us - contact@aarkstore.com / Call us - 91 9987295242

REASONS TO BUY - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Migraine (Central Nervous System).

- Classify potential new clients or partners in the target demographic.

Mail us - contact@aarkstore.com / Call us - 91 9987295242

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Migraine (Central Nervous System) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Mail us - contact@aarkstore.com / Call us - 91 9987295242

BROWSE FULL REPORT @ Report Title - Migraine - Pipeline Review, H2 2017 Report Link - http://www.aarkstore.com/pharmaceuticalshealthcare/648578/migraine-pipeline-review-h2-2017 Order Sample Report - http://www.aarkstore.com/sample/648578 Get Customized Research Report - http://www.aarkstore.com/custom-research.php

Mail us - contact@aarkstore.com / Call us - 91 9987295242

TABLE OF CONTENTS          

Introduction 5 Migraine - Overview 6 Migraine - Therapeutics Development 7 Migraine - Therapeutics Assessment 18 Migraine - Companies Involved in Therapeutics Development 28 Migraine - Drug Profiles 46 Migraine - Dormant Projects 171 Migraine - Discontinued Products 176 Migraine - Product Development Milestones 177 Appendix 192

Mail us - contact@aarkstore.com / Call us - 91 9987295242

RELATED REPORTS • Global Migraine Drugs Industry Market Research Report • Catenin Beta 1 (Beta Catenin or CTNNB1) - Pipeline Review, H2 2017 • Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2017

Mail us - contact@aarkstore.com / Call us - 91 9987295242

ABOUT AARKSTORE

Mail us - contact@aarkstore.com / Call us - 91 9987295242

ENQUIRE US  Mail us at contact@aarkstore.com  24/7 Online Support: +91 9987295242  General Enquiries : +91 - 22 2756 4963

Mail us - contact@aarkstore.com / Call us - 91 9987295242

THANK YOU ď Š Mail us - contact@aarkstore.com / Call us - 91 9987295242